Literature DB >> 25801949

[Successful aging: what can neurology and geriatrics contribute?].

M Synofzik1, W Maetzler.   

Abstract

The relative proportion of elderly persons in Western societies is rapidly growing, leading to an increasing frequency of age-related neurological diseases (e.g. dementia) and functional impairments (e.g. immobility). This article argues that this development should prompt a new focus in medical care. The key questions should not only be how can we improve treatment of age-related disorders but also how can we prevent age-related disorders in the first place or at least substantially delay their onset? These questions touch on an even more profound question: how can successful aging be accomplished? That is, which factors and processes characterize successful aging both on a system and on a molecular level? Thus, the crucial societal, scientific and medical challenges for Western societies are to develop and implement measures of primary prevention of dysfunctional aging. The disease-centered framework which currently determines most clinical thinking, scientific research and third party funding has to be supplemented by a novel framework of successful aging. This article defines dysfunctional aging as a convergent downstream result of multiple interacting system processes. Each of these detrimental system processes must be targeted by specific measures of geriatric primary prevention. This, in turn, implies that geriatrics does not start in the elderly or with the onset of particular geriatric disorders. Instead, it starts in the daily practice of neurology and other medical disciplines taking care of persons aged 20-40 years who are largely healthy and in the middle of their professional and personal career. Or, in a nutshell, geriatrics starts right in the middle of medical care.

Entities:  

Mesh:

Year:  2015        PMID: 25801949     DOI: 10.1007/s00115-014-4194-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  34 in total

1.  [Gait changes as an early indicator of dementia].

Authors:  M Jamour; C Becker; M Synofzik; W Maetzler
Journal:  Z Gerontol Geriatr       Date:  2012-01       Impact factor: 1.281

Review 2.  Emerging therapies for gait disability and balance impairment: promises and pitfalls.

Authors:  Walter Maetzler; Freek Nieuwhof; Sandra E Hasmann; Bastiaan R Bloem
Journal:  Mov Disord       Date:  2013-09-15       Impact factor: 10.338

Review 3.  Brain reserve and the prevention of dementia.

Authors:  Michael J Valenzuela
Journal:  Curr Opin Psychiatry       Date:  2008-05       Impact factor: 4.741

4.  Falls in dementia patients.

Authors:  P T van Dijk; O G Meulenberg; H J van de Sande; J D Habbema
Journal:  Gerontologist       Date:  1993-04

5.  Motoric cognitive risk syndrome and the risk of dementia.

Authors:  Joe Verghese; Cuiling Wang; Richard B Lipton; Roee Holtzer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-17       Impact factor: 6.053

6.  Falls and fractures in patients with Alzheimer-type dementia.

Authors:  D M Buchner; E B Larson
Journal:  JAMA       Date:  1987-03-20       Impact factor: 56.272

7.  Video game-based coordinative training improves ataxia in children with degenerative ataxia.

Authors:  Winfried Ilg; Cornelia Schatton; Julia Schicks; Martin A Giese; Ludger Schöls; Matthis Synofzik
Journal:  Neurology       Date:  2012-10-31       Impact factor: 9.910

Review 8.  Gait and cognition: a complementary approach to understanding brain function and the risk of falling.

Authors:  Manuel Montero-Odasso; Joe Verghese; Olivier Beauchet; Jeffrey M Hausdorff
Journal:  J Am Geriatr Soc       Date:  2012-10-30       Impact factor: 5.562

Review 9.  Exergaming for balance training of elderly: state of the art and future developments.

Authors:  Mike van Diest; Claudine J C Lamoth; Jan Stegenga; Gijsbertus J Verkerke; Klaas Postema
Journal:  J Neuroeng Rehabil       Date:  2013-09-25       Impact factor: 4.262

Review 10.  Motor training in degenerative spinocerebellar disease: ataxia-specific improvements by intensive physiotherapy and exergames.

Authors:  Matthis Synofzik; Winfried Ilg
Journal:  Biomed Res Int       Date:  2014-04-27       Impact factor: 3.411

View more
  2 in total

1.  Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment - the ComOn-study.

Authors:  Johanna Geritz; Sara Maetzold; Maren Steffen; Andrea Pilotto; Marta F Corrà; Mariana Moscovich; Maria C Rizzetti; Barbara Borroni; Alessandro Padovani; Annekathrin Alpes; Corinna Bang; Igor Barcellos; Ralf Baron; Thorsten Bartsch; Jos S Becktepe; Daniela Berg; Lu M Bergeest; Philipp Bergmann; Raquel Bouça-Machado; Michael Drey; Morad Elshehabi; Susan Farahmandi; Joaquim J Ferreira; Andre Franke; Anja Friederich; Corinna Geisler; Philipp Hüllemann; Janne Gierthmühlen; Oliver Granert; Sebastian Heinzel; Maren K Heller; Markus A Hobert; Marc Hofmann; Björn Jemlich; Laura Kerkmann; Stephanie Knüpfer; Katharina Krause; Maximilian Kress; Sonja Krupp; Jennifer Kudelka; Gregor Kuhlenbäumer; Roland Kurth; Frank Leypoldt; Corina Maetzler; Luis F Maia; Andreas Moewius; Patricia Neumann; Katharina Niemann; Christian T Ortlieb; Steffen Paschen; Minh H Pham; Thomas Puehler; Franziska Radloff; Christian Riedel; Marten Rogalski; Simone Sablowsky; Elena M Schanz; Linda Schebesta; Andreas Schicketmüller; Simone Studt; Martina Thieves; Lars Tönges; Sebastian Ullrich; Peter P Urban; Nuno Vila-Chã; Anna Wiegard; Elke Warmerdam; Tobias Warnecke; Michael Weiss; Julius Welzel; Clint Hansen; Walter Maetzler
Journal:  BMC Geriatr       Date:  2020-02-06       Impact factor: 3.921

2.  What contributes most to the SPPB and its subscores in hospitalized geriatric patients: an ICF model-based approach.

Authors:  Jennifer Kudelka; Johanna Geritz; Julius Welzel; Hanna Hildesheim; Corina Maetzler; Kirsten Emmert; Katharina Niemann; Markus A Hobert; Andrea Pilotto; Philipp Bergmann; Walter Maetzler
Journal:  BMC Geriatr       Date:  2022-08-13       Impact factor: 4.070

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.